Epilepsy is associated with excess mortality of two to three times in developed countries. Precise epidemiological data on mortality and cause of death are not available from India or most other developing countries. This study was carried out to estimate the mortality rates and to identify the demographic and clinical characteristics associated with mortality in a hospital based cohort of epilepsy patients. A cohort of patients enrolled in the epilepsy clinic in 1985 was followed up till 1997 (12 years). The mortality rate, demographic and clinical correlate of mortality were analysed for 246 patients (men 161, women 85) who had complete data. Cause of death was not examined in this study. Eighteen (men 15, women 3) of the 246 patients (7.3%) had died during the follow up period of 12 years. The crude death rate for the state of Kerala for the year 1990 (mid period of the study) was 5.9 per thousand population. The demographic and clinical characteristics of those who died (corresponding figures for survivors are given in brackets) were as follows: mean age 33.6 years (22.8 years), presence of abnormal neurological examination 38.9% (15.4%), mental retardation 33.3% (12.8%), abnormal CT scan 38% (21.5%). Regarding the seizure frequency at the time of enrollment and eventual mortality, there were no deaths among patients who had an Engel's seizure score of less than or equal to 4 (no seizures or nocturnal seizures only). The mortality was 5% for an Engel's score of 5 or 6 and 11% for an Engel's score greater than 6. Within the group with epilepsy, higher seizure frequency at the time of initial evaluation was associated with excess mortality. Abnormality on neurological examination, older age group and male sex were other factors that correlated with excess mortality.
INTRODUCTION
Observations from developed countries indicate that mortality is increased by two to three times among people with epilepsy [1] [2] [3] . The excess mortality of epilepsy, mostly at a premature age, constitutes considerable economic burden to the society in terms of quality adjusted life years that are lost. A recent study indicates that mortality due to epilepsy is less when seizures are controlled and greater excess when seizures are not controlled 4 , although there are observations to the contrary too 5 . Data on the natural history and mortality of epilepsy from developing countries are sparse. Nearly 85% of the 40 million people with epilepsy in the world live in developing countries. Various infections of the CNS, and poor obstetric care during birth contribute to the etiology in a larger proportion of cases in these countries. ILAE and WHO have estimated that there is a wide treatment gap in developing countries, with the great majority not receiving any antiepileptic drug treatment 6 . Under these circumstances mortality due to epilepsy is likely to be higher in developing countries. A Medline search did not show any publications on the mortality due to epilepsy in developing countries. This study was carried out to examine the mortality of epilepsy and to identify the demographic and clinical characteristics associated with mortality in India.
MATERIAL AND METHODS
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala State is a leading ter-tiary referral center for cardiac and neurological disorders in South India. Over 8000 patients with epilepsy are enrolled in the comprehensive epilepsy care center attached to this institute. Those patients with epilepsy who were enrolled in 1985 (n = 447) and followed up until 1997 through the epilepsy program of this institute constituted the base population for this study. All patients enrolled in 1985 (n = 447) were called for review in the clinic in 1997. Patients who failed to turn up at the clinic were sent two postal enquiries, the last of which also enquired whether they were alive. Altogether, 246 patients or their family members reported in person or replied through letters. There was no statistically significant difference in the demographic or clinical characteristics between those who were lost for follow up and those who maintained follow up. Family members of 18 patients responded to our enquiries by communicating the death of the patient. Details of death were collected through further enquiries with the family members wherever possible. Clinical details regarding epilepsy were extracted from the medical records maintained in our institute. Seizure frequency was coded according to Engel's score 7 , which scores the seizure count on a logarithmic scale ranging from 0 to 12. A score of less than or equal to 4 indicates no seizures or only nondisabling nocturnal or partial seizures. A score of 5 is 1-3 seizures per year, a score of 6 is 4-11 seizures per year and scores of 7 and above refer to one or more seizures per month. The crude death rate for the middle (1990) of the follow up period (1985-97) for Kerala State was taken as the reference death rate 8 . The data was analysed using a SPSS plus statistical package. Statistical significance of difference in group means was calculated by a t-test and the difference in proportions by a chi-squared test.
RESULTS
A total of 246 patients on whom data were available formed the sample for this study. The median age for the patients was 20 years, which was marginally lower than that for the population of Kerala State (24.4 years) for the year 1990. The epileptic syndromes for these patients were classified as generalized epilepsy 87 (35.3%), localization related epilepsy 145 (58.9%) and others 14 (5.7%). The relative proportion of various epileptic syndromes identified among these patients was comparable to that observed in a communitybased epidemiological study in the same state (generalized epilepsy 30.6%, localization related epilepsy 58.8%, others 10.6%) 9 . At the time of enrollment in the study, the Engel's score of seizure frequency was less than 4 for 11 patients (4.5%), 5-6 for 139 patients (57.2%) and 7 or greater for 93 patients (38.3%). During the study period of 12 years, 18 of the 246 patients (7.3%) had died. The crude mortality rate for Kerala State for the year 1990 was 5.9 per 1000 population 10 . The clinical and demographic details of those who survived are compared with those who died in Table 1 . Death rate was almost three times more among men (9.3%) when compared to women (3.5%). The mean age at the time of enrollment was higher for those who expired (33.6 ± 25.5 years) than for the survivors (22.8 ± 15.3 years). However, both these trends did not achieve statistical significance. The frequency of abnormal neurological findings or the presence of mental retardation was statistically significantly higher among those who died (see Table 1 ).
With regard to the seizure frequency at the time of enrollment and the risk of mortality, there were no deaths among those who had an Engel's score of 4 or less (no seizures or non-disabling partial or nocturnal seizures). The mortality was 5% for an Engel's score of 5 or 6 and 11% for an Engel's score greater than 6.
There was no difference in the type of epilepsy between those who died and those who survived.
DISCUSSION
There are several methodological difficulties in establishing precise mortality statistics for epilepsy 11 . Mortality is usually estimated by community surveys and analysis of hospital data or public records like death certificates. Each method has its own advantages and limitations. Community surveys may be weak on the classification of epileptic syndrome and cause of death. Analyses of autopsy data or death certificates have their limitations because of difficulties in determining the referent population and low recording of epilepsy on death certificates 12 . Very few medical autopsies are carried out in developing countries. The death certification in India until very recently had been under the preview of the revenue department and the cause of death is often not listed satisfactorily. These limitations restrict the feasibility of communitybased studies on mortality due to epilepsy in India. The base data for our study had certain advantages. The patients were drawn from the community without any economic, social or cultural bias. All age groups were represented in this study, although the median age was slightly younger (20 years) when compared to the community (24 years) in Kerala State. Different epileptic syndromes had the same representation as in the community. There was good representation of mild, moderate and severe epilepsy in terms of seizure frequency and the follow up period was reasonably long (maximum of 12 years).
This study gives the broad pattern of mortality for people with epilepsy in India. It was found that 7.3% of epilepsy patients in this study had died during the 12-year period. The crude death rate of this state (for the mid-period of the study-1990) is 5.9 per 1000 population. Based on the annual crude death rate at the mid-period of the study, the expected death rate of Kerala over 12 years is approximately 70.8 per 1000 or 7.1% (5.9 times 12), which appears to be close to the 7.3% observed for the patient cohort. However, there are several fallacies in concluding that the death rates are comparable for both groups. Firstly, the death rate for epilepsy is for a cohort followed up for 12 years, whereas that for the population is for one calendar year (1990). Secondly, the epilepsy group is slightly younger (median age 20 years) than the population (median age 24.4 years) in whom we would expect a lower mortality in contrast to what was observed. Infections, maternal and perinatal causes constitute the majority of deaths (54.6%) in developing countries, whereas they constitute only a small proportion (9%) of deaths in developed countries 13 . It is possible that the extent of mortality due to epilepsy is overshadowed by high mortality due to infections, maternal and perinatal causes. Standardized mortality rates (SMR) could not be calculated as the precise date of death was not available in most cases. Several community based as well as hospital based studies indicate that mortality is increased by two to three times in people with epilepsy 1-3, 11, 12, 14 . The mortality observed in this cohort is comparable to that reported from another tertiary care center in the UK 15 .
In this study, there was a clear preponderance for more deaths among men (9.3%) than women (3.5%).
Most other studies have also observed that mortality is higher for men than women 1, 12, 14 . The results reveal that the mean age for the expired group was higher (33.6 years) than that for the survivors (22.8 years), although it did not reach statistical significance. Studies from the Netherlands reveal that mortality is higher among those aged less than 20 years compared to those above 20 years 2 . The excess mortality among children may be reflecting the underlying neurological disorder or severity of epilepsy and relatively low mortality among healthy children 1 .
Other factors that correlated with mortality in this study were abnormal neurological examination, presence of mental retardation, and higher seizure frequency. The presence of co-morbidities probably indicates an underlying remote symptomatic cause for epilepsy. Similar observations have been made in community based studies as well as hospital based studies from elsewhere. In this study there was no correlation between the type of epilepsy and increased mortality. Olafsson et al. noticed that the increased mortality in epilepsy is primarily due to greater mortality in patients with remote symptomatic seizures, whereas the mortality for idiopathic unprovoked seizures was not significantly increased 16 .
With regard to the severity of epilepsy, there were no deaths among patients who were seizure free. Mortality was increased as the frequency of seizures increased. Previous studies have also indicated that the relative risk of death increases with persistent seizures 1 . In a study from the USA, the SMR for patients with recurrent seizures was 4.69, whereas among the patients who became seizure free, there was no difference in mortality rate compared with the age and sex matched population 17 . These observations indicate that effective control of seizures would probably reduce the mortality of epilepsy.
Cause of death was not explored in this study. Studies from developed countries have revealed that excess mortality in a younger age group was due to remote symptomatic causes while among an older age group the causes were often accidental deaths including suicide 14 . Sudden unexpected death constitutes a major proportion of deaths among young people. No such analysis was attempted in this study. It is recognized that medical certification of cause of death is a poor source of information in the case of epilepsy and other chronic disorders with low case fatality rates. Epilepsy may not be mentioned as the primary or secondary cause of death in most cases. In this study, there is no satisfactory certification of cause of death. Many of the subjects had died outside formal medical services.
This study has highlighted the difficulties in evaluating mortality of epilepsy in a developing country. Our salient observations were that the mortality pattern for epilepsy in India is comparable to elsewhere, and that there is a correlation between the presence of co-morbidities and poor control of seizures with mortality for epilepsy. Further studies on the mortality of epilepsy in developing countries are essential to improve epilepsy care and quality of life for people with epilepsy.
